Company lists · Data refreshed September 2026

Top 18 Rare disease drug manufacturers based in Switzerland

RevenueBase identified 30 rare disease drug manufacturers headquartered in Switzerland as of September 2026 and tracks 2,752 professional contacts across them, including 677 with verified work emails. Allschwil is the largest hub.

This list covers rare disease drug manufacturers headquartered in Switzerland, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 17, 2026.

Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.

How to read this list HQ checked on every row RevenueBase Smart Search rating on every row Refreshed Sep 17, 2026 86% judged on-target in blind review
30Companies
2,752Contacts tracked
677Verified emails
Explore this list → Free signup · no credit card · 500 free credits

The 18 largest rare disease drug manufacturers based in Switzerland

Ranked by team size
Top 18 of 30 rare disease drug manufacturers based in Switzerland, ranked by team size, largest first. Data refreshed Sep 17, 2026. RevenueBase Smart Search rates how each company's information relates to rare disease drug manufacturers: strong evidence (its own description names it), partial (names part of it), indirect (matched on the rest of its profile rather than the description shown). Click a contact count to view that company's people.
#CompanyRevenueBase Smart SearchHeadquartersEmployeesContacts
1Indirect evidenceAllschwil, SwitzerlandHQ checked Sep 17, 2026501-1,000644 contacts →

Indirect evidence

“The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients.”

Source: RevenueBase Database · checked Sep 17, 2026
2Partial evidencePratteln, SwitzerlandHQ checked Sep 17, 202651-200113 contacts →

Partial evidence

“Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular…”

Source: RevenueBase Database · checked Sep 17, 2026
3Indirect evidenceCh-8152 Glattpark (opfikon), SwitzerlandHQ checked Sep 17, 202651-20098 contacts →

Indirect evidence

“TAKEDA PHARMACEUTICALS INTERNATIONAL GMBH GLATTPARK CH is a wholesale company based out of THURGAUERSTRASSE 130, Ch-8152 Glattpark (Opfikon), Switzerland.”

Source: RevenueBase Database · checked Sep 17, 2026
4Indirect evidenceLugano, SwitzerlandHQ checked Sep 17, 202651-20080 contacts →

Indirect evidence

“ADIENNE is an integrated biopharmaceutical group of companies based in Lugano, Switzerland, with a proprietary portfolio of orphan-designated marketed medicinal product, clinical…”

Source: RevenueBase Database · checked Sep 17, 2026
5Partial evidencePratteln, SwitzerlandHQ checked Sep 17, 2026201-50052 contacts →

Partial evidence

“Develco Pharma is a privately owned company operating in the field of development and manufacture of pharmaceutical products.”

Source: RevenueBase Database · checked Sep 17, 2026
6Indirect evidenceBalerna, SwitzerlandHQ checked Sep 17, 202611-5033 contacts →

Indirect evidence

“APR (part of Relief Therapeutics) is a Swiss-based international biopharmaceutical company focused on development and global commercialization of innovative, research-driven…”

Source: RevenueBase Database · checked Sep 17, 2026
7Indirect evidenceBasel, SwitzerlandHQ checked Sep 17, 202611-5024 contacts →

Indirect evidence

“At Eumedica we offer an extensive range of products and services, covering healthcare stakeholders' need, in three domains of expertise- Manufacturing Active Pharmaceutical…”

Source: RevenueBase Database · checked Sep 17, 2026
8Strong evidenceAllschwil, SwitzerlandHQ checked Sep 17, 202611-5021 contacts →

Strong evidence

“Spexis AG (SIX:SPEX) is a publicly-listed Swiss clinical-stage biopharmaceutical company developing rare disease and oncology treatments in indications where new therapeutic…”

Source: RevenueBase Database · checked Sep 17, 2026
9Indirect evidenceKüsnacht, SwitzerlandHQ checked Sep 17, 202611-5016 contacts →

Indirect evidence

“OrPha Swiss ist eine Schweizer Pharmafirma, die sich vor allem auf die medikamentöse Therapie von seltenen Erkrankungen (sog.”

Source: RevenueBase Database · checked Sep 17, 2026
10Indirect evidenceBasel, SwitzerlandHQ checked Sep 17, 202611-5010 contacts →

Indirect evidence

“Sobi widmet sich der Entwicklung und Durchführung von innovativen Therapien, die das Leben von Patienten mit seltenen Erkrankungen verbessern.”

Source: RevenueBase Database · checked Sep 17, 2026
11Indirect evidenceLiestal, SwitzerlandHQ checked Sep 17, 20261-107 contacts →

Indirect evidence

“Curatis is a specialty pharmaceutical company based in Switzerland.”

Source: RevenueBase Database · checked Sep 17, 2026
12Indirect evidenceZug, SwitzerlandHQ checked Sep 17, 20261-106 contacts →

Indirect evidence

“We are on a mission to enhance standard of care therapies by developing innovative, cost-effective solutions that tackle critical unmet medical needs, and genuinely improve…”

Source: RevenueBase Database · checked Sep 17, 2026
13Indirect evidenceZurich, SwitzerlandHQ checked Sep 17, 20261-104 contacts →

Indirect evidence

“Galepharm is the marketing authorisation holder of prescription-only niche preparations – these are important medicines that are hardly available anymore today but are often…”

Source: RevenueBase Database · checked Sep 17, 2026
14Partial evidenceBasel, SwitzerlandHQ checked Sep 17, 20261-104 contacts →

Partial evidence

“Landmark BioVentures is an integrative corporate and drug development company using resources smartly to advance multiple innovative therapies.”

Source: RevenueBase Database · checked Sep 17, 2026
15Strong evidenceGeneve, SwitzerlandHQ checked Sep 17, 202611-504 contacts →

Strong evidence

“RELIEF THERAPEUTICS Holding SA (SIX: RLF; OTCQB: RLFTF, RLFTY) We are a biopharmaceutical company committed to providing therapeutic relief to patients living with rare diseases.”

Source: RevenueBase Database · checked Sep 17, 2026
16Strong evidencePully, SwitzerlandHQ checked Sep 17, 202611-502 contacts →

Strong evidence

“Founded in 2004 CarthaGenetics® provides specialized consulting services for companies developing rare disease treatments, advanced therapies, and orphan drugs seeking to navigate…”

Source: RevenueBase Database · checked Sep 17, 2026
17Partial evidenceBaar, SwitzerlandHQ checked Sep 17, 20261-102 contacts →

Partial evidence

“We develop, register and manufacture (generic) finished formulations and corresponding dossiers under own sponsorship or in cooperation with renowned partner.”

Source: RevenueBase Database · checked Sep 17, 2026
18Indirect evidenceBasel, SwitzerlandHQ checked Sep 17, 20261-101 contacts →

Indirect evidence

“We discover medicines, derived from complex natural products.”

Source: RevenueBase Database · checked Sep 17, 2026

Showing 18 of 30 rare disease drug manufacturers based in Switzerland

See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 677 reachable decision-makers.

Free signup · no credit card

View the full list →

Rare disease drug manufacturers based in Switzerland at a glance

As of Sep 17, 2026
24.6%Verified-email coverage
91.7Average contacts per company
11-50Median size (employees)
10.0%Largest-city concentration · Allschwil
Sep 17, 2026Page data refreshed

Companies by employee count

1-10
10
11-50
10
51-200
6
201-500
1
501-1,000
1
1,001-5,000
1
10001+
1

Email recency for this list is measured worldwide rather than for Switzerland, so it is reported there. Company counts and contact totals on this page are exact for Switzerland, over 30 companies.

How this list was built

Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among rare disease drug manufacturers, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.

Source
The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
What qualifies
Companies headquartered in Switzerland whose own description of what they do matches “rare disease drug manufacturers”. Matching reads each company's description, not its industry code or its name.
RevenueBase Smart Search
RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names rare disease drug manufacturers), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
What we exclude
Companies whose own description does not clearly place them among rare disease drug manufacturers, and records with no verified work email. Companies headquartered outside Switzerland are excluded even when they keep an office there.
Match quality
In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
Ranking
Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
Verification
Every listed company carries at least one verified work email, 677 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
Refresh
This page's figures were pulled from the company graph on September 17, 2026. Lists refresh periodically as the graph is re-checked.
Corrections
Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.

Frequently asked

What is RevenueBase Smart Search?

RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names rare disease drug manufacturers, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.

How many rare disease drug manufacturers are there based in Switzerland?

RevenueBase identified 30 rare disease drug manufacturers headquartered in Switzerland as of September 2026, matched on each company's own description of what it does rather than its industry code.

What is the largest company on this list?

Idorsia Pharmaceuticals LTD, headquartered in Allschwil, tops this list with the largest team on record.

Which city has the most rare disease drug manufacturers?

Allschwil leads with 3 headquartered companies, followed by Basel (3) and Zurich (3).

How do I get contact information for these companies?

A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 677 verified decision-maker contacts tracked across these 30 companies.

How current is this list?

The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 17, 2026.

Ready to reach these companies? Verified emails and direct dials for all 30 rare disease drug manufacturers based in Switzerland. Start with a free account, no credit card.

Download this list →

Related lists

About this data

RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.